documents: FDA-2019-D-5473-0028
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2019-D-5473-0028 | FDA | FDA-2019-D-5473 | Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and Interchangeable Biosimilar Products: Questions and Answers; Guidance for Industry; Availability | Notice | Notice of Availability | 2025-12-10T05:00:00Z | 2025 | 12 | 2025-12-10T20:21:09Z | 2025-22427 | 0 | 0 | 09000064b90c159b |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref